|
Volumn 249, Issue 3, 2011, Pages 455-458
|
Primary intravitreal ranibizumab for adult-onset foveomacular vitelliform dystrophy
|
Author keywords
Adult onset foveomacular vitelliform dystrophy; Macular dystrophy; Ranibizumab
|
Indexed keywords
INDOCYANINE GREEN;
RANIBIZUMAB;
ADULT ONSET FOVEOMACULAR VITELLIFORM DYSTROPHY;
AGED;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL EVALUATION;
DIAGNOSTIC ERROR;
DIFFERENTIAL DIAGNOSIS;
DRUG EFFICACY;
ELECTROOCULOGRAM;
ELECTRORETINOGRAM;
FEMALE;
HUMAN;
INDOCYANINE GREEN ANGIOGRAPHY;
OPTICAL COHERENCE TOMOGRAPHY;
PRIORITY JOURNAL;
RETINA MACULA VITELLIFORM DEGENERATION;
SUBRETINAL NEOVASCULARIZATION;
TREATMENT DURATION;
VISUAL ACUITY;
VISUAL IMPAIRMENT;
AGED;
AGED, 80 AND OVER;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
COLORING AGENTS;
FEMALE;
FLUORESCEIN ANGIOGRAPHY;
HUMANS;
INDOCYANINE GREEN;
INTRAVITREAL INJECTIONS;
TOMOGRAPHY, OPTICAL COHERENCE;
TREATMENT OUTCOME;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VISUAL ACUITY;
VITELLIFORM MACULAR DYSTROPHY;
|
EID: 79955628613
PISSN: 0721832X
EISSN: None
Source Type: Journal
DOI: 10.1007/s00417-010-1536-1 Document Type: Article |
Times cited : (19)
|
References (7)
|